Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancer.
about
Reliability of quantitative ultrasonic assessment of normal-tissue toxicity in breast cancer radiotherapy.Feasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast cancer.Breast cancer local recurrence under the form of inflammatory carcinoma, treated with concurrent radiation and chemotherapy, a case reportHyperthermia for locally advanced breast cancer.Concurrent chemoradiotherapy for locally advanced breast cancer-time for a new paradigm?Esophageal carcinoma: current controversial topics.Role of chemotherapy in breast cancer.Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy.ACR appropriateness criteria® locally advanced breast cancer.Overview on cardiac, pulmonary and cutaneous toxicity in patients treated with adjuvant radiotherapy for breast cancer.Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel.Radiotherapy with concurrent docetaxel for advanced and recurrent breast cancer.Radiation pneumonitis in breast cancer patients treated with taxanes: does sequential radiation therapy lower the risk?Breast-conserving therapy with adjuvant paclitaxel and radiation therapy: feasibility of concurrent treatment.Grade III Dermatitis in a Patient Treated With Paclitaxel and Radiotherapy: Case Report and Review of the Literature.Acute and subacute toxicity associated with concurrent adjuvant radiation therapy and paclitaxel in primary breast cancer therapy.
P2860
Q30458600-6D644E55-C67A-4248-9EE0-33FB0FA3940CQ33383943-3ABB8816-E575-43D2-8C88-F97D8683CC90Q33751728-8A725EA9-93EF-44DF-B0DE-1E93D8EA92C4Q34171535-F2C7C591-21C6-45F5-A110-E9BBE91D18F0Q35072438-6D894DAF-3BDA-4DC4-AF42-A9B649DFE79DQ36004899-82F55F2D-43C5-4B93-8043-B851CA8A211EQ36334921-EFA9A5FF-EFEC-45F8-8B94-0556F51B298EQ37605623-61CCAE67-8C5F-49D9-8E03-8F6CAD02D22FQ37929856-021649C4-C2FD-4BFF-A13B-DC4C3B6D28C2Q38792791-24FC9265-5F4C-44ED-8F67-AE6EFA96D806Q43816485-A9FBE34E-183E-4CAB-8B2A-2C904760CCF8Q44573107-4F922B67-9F32-40E3-B395-339BEC12B2B3Q44673877-F43B2731-91CE-4C9F-8842-29C8BD0CD773Q46521479-C3BDA83B-B8AC-415B-9697-4960178F3E33Q47136665-B675C329-D253-4F4F-972D-EC32EBBC4D8FQ53872568-AED1BDE1-0028-412E-8EFF-10D64FAC80BE
P2860
Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancer.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Concurrent radiation therapy a ...... py in high-risk breast cancer.
@ast
Concurrent radiation therapy a ...... py in high-risk breast cancer.
@en
Concurrent radiation therapy a ...... py in high-risk breast cancer.
@nl
type
label
Concurrent radiation therapy a ...... py in high-risk breast cancer.
@ast
Concurrent radiation therapy a ...... py in high-risk breast cancer.
@en
Concurrent radiation therapy a ...... py in high-risk breast cancer.
@nl
prefLabel
Concurrent radiation therapy a ...... py in high-risk breast cancer.
@ast
Concurrent radiation therapy a ...... py in high-risk breast cancer.
@en
Concurrent radiation therapy a ...... py in high-risk breast cancer.
@nl
P2093
P1476
Concurrent radiation therapy a ...... py in high-risk breast cancer.
@en
P2093
J R Bellon
J R Gralow
K L Lindsley
M M Austin Seymour
R B Livingston
P304
P356
10.1016/S0360-3016(00)00636-2
P407
P577
2000-09-01T00:00:00Z